Aging is universally characterized by a progressive breakdown of intestinal barrier functions and an increasingly impaired oxidative balance. An industry-backed pilot study from Polish researchers investigates whether a concentrated dose of a specific probiotic strain—Lactiplantibacillus plantarum OL3246—can mitigate this systemic decline when introduced into the aging gut. The trial tracked a small cohort of generally healthy older adults, predominantly women in their early 70s, who ingested the probiotic or a placebo daily for three months. While most probiotic research targets overt gastrointestinal pathology, this trial explicitly aimed at “healthy aging,” hunting for subtle shifts in quality of life (QoL), mood, and molecular warning signs of neurodegeneration.
The clinical results demonstrate a distinct divergence between the cohorts. The probiotic group reported statistically significant improvements in self-assessed QoL (via the SF-36 scale) and mild depressive symptoms (via the BDI scale) compared to the placebo group. Concurrently, researchers observed a sharp drop in fecal calprotectin among the treated subjects, signaling a reduction in localized intestinal inflammation.
The most compelling biological signals, however, were found in the blood. The probiotic appeared to disrupt the standard correlation between systemic oxidative stress and neurodegeneration-linked proteins. In the placebo group, as levels of the oxidative stress marker Superoxide Dismutase (SOD) rose, so did levels of alpha-synuclein—a protein implicated in proteotoxicity and Parkinson’s disease. In the L. plantarum OL3246 group, this correlation was entirely decoupled, and the accumulation of Advanced Oxidation Protein Products (AOPP) was significantly suppressed. Fecal sequencing confirmed an ecological shift, notably boosting populations of Faecalibacterium prausnitzii, a keystone microbe known for producing anti-inflammatory short-chain fatty acids.
These preliminary data suggest that targeted microbiome modulation may serve as a low-risk strategy for maintaining systemic redox balance and preserving emotional resilience in late life. However, due to the severely limited sample size and cohort homogeneity, translating these biomarker shifts into guaranteed long-term healthspan extension remains highly speculative.
Source:
2 Likes
The former name was Lactobacillus plantarum. Strains KABP-022 and KABP-023 are common. I wonder how close OL3246 is in terms of effect.
2 Likes
First blush, I see this:
Taxonomic Background: The Great Reclassification of 2020
The shift from Lactobacillus plantarum to Lactiplantibacillus plantarum was not a simple clerical update; it was a fundamental overhaul of a genus that had become a “polyphyletic dumping ground” for nearly any rod-shaped, lactic acid-producing bacterium.
In April 2020, a landmark study published in the International Journal of Systematic and Evolutionary Microbiology (Zheng et al., 2020) used whole-genome sequencing (WGS) and Average Nucleotide Identity (ANI) to split the genus into 25 new genera .
-
Rationale: The genetic diversity within the old Lactobacillus genus was actually greater than the diversity across many other mammalian families.
-
The New Genus: Lactiplantibacillus (Lacti- “lactic acid,” planti- “associated with plants,” bacillus- “rod”) was created specifically to house L. plantarum and its close relatives, reflecting their unique ecological versatility and metabolic robustness.
Strain-Specific Comparisons: KABP-022/023 vs. OL3246
While all three belong to the same species, their “functional similarity” is high regarding their basic resilience (acid/bile tolerance), but their clinical applications are distinct.
1. Functional Similarity (The Core Genome)
As members of the L. plantarum species, all three strains share high levels of technological robustness:
-
Genomic Plasticity: They possess one of the largest genomes among lactic acid bacteria, allowing them to adapt to diverse environments (from plant fermentation to the human GI tract).
-
Resilience: High tolerance to low pH and bile salts, ensuring survival during gastric transit.
-
Metabolic Profile: Facultative heterofermentative, capable of fermenting a wide range of carbohydrates.
2. Clinical Specialization (The Strain Divergence)
| Feature |
KABP-022 & KABP-023 |
OL3246 |
| Primary Target |
Gut-Brain & IBS-D |
Healthy Aging & Oxidative Stress |
| Key Clinical Data |
Often used in a blend (with KABP-021) to reduce diarrhea-related symptoms and stress-induced GI distress. |
Shown in 2026 pilot studies to reduce fecal calprotectin and zonulin (markers of intestinal inflammation/leaky gut). |
| Mechanism |
Enhances Faecalibacterium abundance; modulates the gut-brain axis under stressful conditions. |
Restoration of redox balance (stabilizing SOD, lowering AOPP) and modulating “inflammaging.” |
| Population Focus |
Healthy adults under high stress. |
Elderly populations with low-grade systemic inflammation. |
Comparative Analysis: High-Probability Findings
-
Anti-Inflammatory Synergy: There is high theoretical support for the idea that while KABP-022/023 target acute stress-response symptoms, OL3246 offers a more robust “shield” against the chronic, low-grade inflammation associated with aging.
-
Microbiota Modulation: Both groups are proven to increase the abundance of health-associated taxa (like Faecalibacterium), but they likely do so through different secondary metabolite pathways.
-
Regulatory Transition: By regulatory mandate (e.g., Health Canada/EFSA), you will see the "Formerly Lactobacillus " nomenclature on labels until roughly 2028, after which the Lactiplantibacillus name will become the exclusive standard.
Speculative Perspectives
A burgeoning area of interest—and one quite speculative given current data—is the potential for synergistic “geroprotective” pulses. Given your interest in mitochondrial health, combining the acute stress-modulation of the KABP strains with the redox-stabilizing properties of OL3246 could theoretically offer a broader spectrum of cellular resilience than either alone, though clinical trials for this combination have yet to be published.
2 Likes